tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BioNTech and Bristol-Myers Squibb Advance Pumitamig Trial in Aggressive Brain Cancer
PremiumCompany AnnouncementsBioNTech and Bristol-Myers Squibb Advance Pumitamig Trial in Aggressive Brain Cancer
21d ago
Goldman Sachs Picks 2 Stocks That Let Investors Buy the Dip or Ride the Momentum
Premium
Stock Analysis & Ideas
Goldman Sachs Picks 2 Stocks That Let Investors Buy the Dip or Ride the Momentum
21d ago
BioNTech Adds Chief People Officer to Management Board to Support Oncology Growth Strategy
Premium
Company Announcements
BioNTech Adds Chief People Officer to Management Board to Support Oncology Growth Strategy
23d ago
Bristol-Myers Squibb and BioNTech Advance New Lung Cancer Weapon Against Keytruda in Phase 3 Trial
PremiumCompany AnnouncementsBristol-Myers Squibb and BioNTech Advance New Lung Cancer Weapon Against Keytruda in Phase 3 Trial
28d ago
Moderna Stock (MRNA) Hits a New 52-Week High — Can the Rally Last Through 2026?
Premium
Market News
Moderna Stock (MRNA) Hits a New 52-Week High — Can the Rally Last Through 2026?
29d ago
BioNTech’s BNT142 Trial Termination: What It Means for the Oncology Pipeline and Investors
Premium
Company Announcements
BioNTech’s BNT142 Trial Termination: What It Means for the Oncology Pipeline and Investors
30d ago
BioNTech upgraded to Buy at Goldman Sachs on cancer potential
PremiumThe FlyBioNTech upgraded to Buy at Goldman Sachs on cancer potential
1M ago
BioNTech Outlines 2026 Strategy and Milestones at J.P. Morgan Healthcare Conference
Premium
Company Announcements
BioNTech Outlines 2026 Strategy and Milestones at J.P. Morgan Healthcare Conference
1M ago
BioNTech: Stable COVID-19 Vaccine Base and Catalyst-Rich Oncology Pipeline Support Buy Rating
Premium
Ratings
BioNTech: Stable COVID-19 Vaccine Base and Catalyst-Rich Oncology Pipeline Support Buy Rating
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100